{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:11:47Z","timestamp":1792005107218,"version":"4.4.0"},"reference-count":19,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T00:00:00Z","timestamp":1619740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Radiation recall pneumonitis (RRP) is a poorly understood clinical syndrome in which patients develop radiation pneumonitis triggered by a systemic agent, often years after the completion of radiation therapy. Immune checkpoint blockade agents have only recently been posited as a trigger for RRP. Here, we present three cases of immunotherapy-induced RRP.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Presentation<\/jats:title><jats:p>Our first patient was diagnosed with primary lung adenocarcinoma, and 4.5 years after completing radiation therapy developed symptomatic RRP immediately following a second dose of nivolumab-containing immunotherapy regimen. Our second patient was diagnosed with primary bladder cancer metastatic to the mediastinum, which was treated twice with radiation therapy. He developed RRP in the days following his second course of ipilimumab-pembrolizumab which was months after his second course of radiation that he received. Our final patient was diagnosed with metastatic small cell lung cancer and received local consolidative radiation therapy in addition to whole-brain radiation. He developed RRP on the 11<jats:sup>th<\/jats:sup> day after concluding his 4<jats:sup>th<\/jats:sup> cycle of nivolumab-ipilimumab, approximately 7 months after having had completed chest radiation therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Immunotherapy-induced RRP is a rare diagnosis which can present more focally than traditional immunotherapy pneumonitis and which must be clinically differentiated from other local processes such as pneumonia. Further research should explore the mechanisms underlying these radiation recall reactions as many patients receive radiation and immunotherapy during the course of their cancer treatment.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fonc.2021.662954","type":"journal-article","created":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T17:06:11Z","timestamp":1619802371000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":26,"title":["Radiation Recall Pneumonitis After Treatment With Checkpoint Blockade Immunotherapy: A Case Series and Review of Literature"],"prefix":"10.3389","volume":"11","author":[{"given":"Paul","family":"Riviere","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Sumner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariel","family":"Cornell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jona","family":"Hattangadi-Gluth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Bruggeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangwoo S.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Michael","family":"Randall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew B.","family":"Sharabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,4,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2009-0090","article-title":"Radiation Recall With Anticancer Agents","volume":"15","author":"Burris","year":"2010","journal-title":"Oncologist"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctrv.2005.07.008","article-title":"Radiation Recall: A Well Recognized But Neglected Phenomenon","volume":"31","author":"Azria","year":"2005","journal-title":"Cancer Treat Rev"},{"key":"B3","article-title":"Radiation Recall Reaction Induced by Levofloxacin","volume":"7","author":"Cho","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.2310\/7750.2014.14135","article-title":"Recall Dermatitis to Metronidazole","volume":"19","author":"Mussani","year":"2015","journal-title":"J Cutan Med Surg"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccm.2016.12.004","article-title":"Radiation Pneumonitis","volume":"38","author":"Bledsoe","year":"2017","journal-title":"Clin Chest Med"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1186\/1748-717X-6-24","article-title":"Radiation Recall Pneumonitis Induced by Chemotherapy After Thoracic Radiotherapy for Lung Cancer","volume":"6","author":"Ding","year":"2011","journal-title":"Radiat Oncol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s00066-007-1688-z","article-title":"Radiation Recall Pneumonitis Induced by Gemcitabine","volume":"183","author":"Schwarte","year":"2007","journal-title":"Strahlenther Onkol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/s0360-3016(02)02773-6","article-title":"Gemcitabine-Induced Radiation Recall","volume":"53","author":"Jeter","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3727\/096504015X14400775740416","article-title":"Radiation Recall Pneumonitis During Systemic Treatment With Everolimus","volume":"22","author":"Clark","year":"2014","journal-title":"Oncol Res"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1159\/000337616","article-title":"Radiation Recall Pneumonitis Caused by Erlotinib After Palliative Definitive Radiotherapy","volume":"35","author":"Onal","year":"2012","journal-title":"Onkologie"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdq444","article-title":"Recall Pneumonitis During Systemic Treatment With Sunitinib","volume":"21","author":"Seidel","year":"2010","journal-title":"Ann Oncol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"FSO378","DOI":"10.2144\/fsoa-2018-0123","article-title":"Radiation Recall Pneumonitis in the Setting of Immunotherapy and Radiation: A Focused Review","volume":"5","author":"McGovern","year":"2019","journal-title":"Future Sci OA"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx115","article-title":"Nivolumab Induced Radiation Recall Pneumonitis After Two Years of Radiotherapy","volume":"28","author":"Shibaki","year":"2017","journal-title":"Ann Oncol"},{"key":"B14","article-title":"Radiation Recall Pneumonitis in a Patient Treated by Nivolumab for Non-Small Cell Lung Cancer, No Relapse With Rechallenge","volume":"23","author":"Thor\u00e9","year":"2018","journal-title":"Eur J Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2015-0498","article-title":"Fda Approval Summary: Pembrolizumab for the Treatment of Patients With Metastatic non-Small Cell Lung Cancer Whose Tumors Express Programmed Death-Ligand 1","volume":"21","author":"Sul","year":"2016","journal-title":"Oncologist"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2018.08.2035","article-title":"Pneumonitis in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Immunotherapy: Incidence and Risk Factors","volume":"13","author":"Suresh","year":"2018","journal-title":"J Thorac Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.cllc.2019.02.018","article-title":"Relationship Between Prior Radiotherapy and Checkpoint-Inhibitor Pneumonitis in Patients With Advanced Non-Small-Cell Lung Cancer","volume":"20","author":"Voong","year":"2019","journal-title":"Clin Lung Cancer"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1007\/s10227-001-0156-0","article-title":"Histopathologic Features Seen With Radiation Recall or Enhancement Eruptions","volume":"6","author":"Smith","year":"2002","journal-title":"J Cutaneous Med Surgery: Incorporating Med Surg Dermatol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.77.5593","article-title":"Postmarketing Modifications of Drug Labels for Cancer Drugs Approved by the US Food and Drug Administration Between 2006 and 2016 With and Without Supporting Randomized Controlled Trials","volume":"36","author":"Shepshelovich","year":"2018","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.662954\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,30]],"date-time":"2021-04-30T17:06:14Z","timestamp":1619802374000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2021.662954\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,30]]},"references-count":19,"alternative-id":["10.3389\/fonc.2021.662954"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2021.662954","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,30]]},"article-number":"662954"}}